As #ASCO23 winds down, reaching out to #OncTwitter to spread the word that our #littleEngine cancer program at the Birmingham VA is quickly growing and we are hiring more faculty! J1 waiver could be considered! DM me or email me if interested in details @HemOncFellows
Looking forward to moderating this case-based panel on the management of GTN. Thrilled to be joined by expert colleagues @benoityoulyon, @kevin_elias & Dr. John Soper. Join us for a great discussion of critical aspects of caring for patients w/this diagnosis! #gyncsm#ASCO23
June 2 #lcsm#oncmeded#EGFR#ASCO23
🛑 Clinical question: ❓ Optimum timing of EGFR therapy and sequencing
🛑 Quick Review paper for context and to help critically appraise the abstracts 📝
https://t.co/Rtj0hPnjhA
‼️Come back to discuss post presentation! 🔈
Where are my virtual/hybrid #ASCO23 folks at? No need for FOMO!
Let’s break it down 1 day at a time! 💁🏽♀️
For June 2nd - some Edu sessions are live stream and rest on demand!
🛑 Pictures for the #lcsm focused sessions!
🛑 Sessions start at 1CST
See ya! ☕️ 🖥️
@ASCO
Mentees can now sign up for one-on-one mentoring in the Publications Lounge via the link below. Sign up here: 🚨 https://t.co/DzMY0CgAZP
#ASCO2023@ASCO@JCO_ASCO
It was the best thing that happened to me and now happy to pay it forward!! Several female faculty are volunteering their time to provide career guidance and other valuable work/life skills discussions at #ASCO2023 Check it out! (and sign up) 🚨
https://t.co/yBh0uy3O5O
Poll alert ‼️ Academic centers with endowed chair positions for clinical/educator faculty? 🦄 (asking as part of a project) if yes- please do comment where and 🙌 it’s commendable) #Medtwitter@HemOncWomenDocs#WomenInMedicine
Friday Fury!
➡️Drug shortages in oncology- we need more visibility on this topic and a plan to fix it! 🙏🏽
➡️Continued reliance on Faxes 📠 in health care data transfer (make it go away) 🛑❌ #womeninmedicine#lcsm@HemOncWomenDocs@HOJournalClub
Good morning Washington DC from some of the women of @asco. We’re passionate about improving cancer care in America and we’ve got something to say. #ASCOAdvocacySummit
So excited for this important event - honored to be included as a panelist and share my perspective as an #oncology PD. Look forward to the discussions and to learning from this all-🌟 group. @ASCO@UFHealthCancer#ASCO23#OncMedEd
"Hear Me Out": Cisplatin-induced #ototoxicity remains an essential concern in the modern era... harm minimization via effective monitoring and rehabilitation must be optimized. ➡️ https://t.co/N8kXuc5W6s @ADesaiMD@DevikaDasMD